Non-alcoholic Fatty Liver Disease

Insulin resistance disrupts normal lipid regulation, increasing the delivery and synthesis of fatty acids in the liver. When these inputs exceed the organ’s capacity to oxidize fatty acids or export lipids, fat accumulates within hepatocytes. This imbalance helps connect systemic metabolic dysfunction with liver steatosis and provides a central mechanism for studying NAFLD biology.

Persistent steatosis can place hepatocytes under metabolic stress, promoting oxidative stress and inflammation. Continued tissue injury may then stimulate progressive fibrosis, in which excess fibrous tissue alters liver structure. This sequence explains why fatty accumulation is not only a storage abnormality but can also precede advanced outcomes such as cirrhosis and liver cancer.

Progression depends on whether lipid delivery and synthesis continue to exceed oxidation and export. Sustained imbalance favors ongoing steatosis, while associated oxidative stress and inflammation increase the likelihood of tissue injury. In biological studies, examining these linked processes helps distinguish metabolic fat accumulation from the later changes associated with fibrosis and more severe liver disease.

Researchers combine liver enzymes, imaging, metabolic assessments, and histology to characterize disease severity. These approaches examine complementary features rather than relying on a single measurement: biochemical indicators, liver appearance, metabolic status, and tissue-level changes. Together, they help evaluate the extent of steatosis and fibrosis and support comparisons across patients or experimental conditions.

Histology provides tissue-level information that other assessments may not capture, allowing researchers to examine structural changes associated with steatosis, inflammation, and fibrosis. Used alongside liver enzymes, imaging, and metabolic assessments, it strengthens characterization of disease severity. This combined approach is especially useful when evaluating how biological interventions influence liver injury and progression.

NAFLD links metabolism, inflammation, and tissue injury within one disease process, making it useful for investigating how these biological systems interact. Researchers can use assessments such as imaging, metabolic measurements, liver enzymes, and histology to characterize changes and evaluate preventive or therapeutic strategies. Findings may clarify mechanisms that connect metabolic imbalance with progressive liver damage.